Parasitic Stool Panel II PCR Kit

$1,820.00
Catalog
86-PS2HU-100
The Parasitic Stool Panel II is a multiplex real-time PCR assay for the direct, qualitative detection and differentiation of Giardia lamblia, Cryptosporidium spp. and Entamoeba histolytica in human stool samples. Research Use Only. Not for Use in Diagnostic Procedures.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in North America Only
Sensitivity
≥ 10 DNA copies
Sizes
100 Tests
Sample Types
Stool
Inc Time Hour
< 1.5
Inc Time Overnight
No
Inc Time See Protocol
No
Detection
Fluorescence
The Parasitic Stool Panel II PCR Kit has been tested on Roche LightCycler 480II, Agilent Technologies Mx3005P, Applied Biosystems ABI 7500, Bio-Rad CFX96, and QIAGEN Rotor-Gene Q real-time PCR instruments.  The Parasitic Stool Panel II is a multiplex real-time PCR assay for the direct, qualitative detection and differentiation of Giardia lamblia (G. lamblia), Cryptosporidium spp. and Entamoeba histolytica (E. histolytica) in human stool samples. After DNA isolation, amplification of gene fragments (ITS1-18S, if present) specific for G. lamblia, Cryptosporidium spp. and E. histolytica occurs if present. The amplified targets for G. lamblia, Cryptosporidium spp. and E. histolytica are detected with hydrolysis probes, which are labelled at one end with a quencher and at the other end with a fluorescent reporter dye (fluorophore). In the presence of a target the probes hybridize to the amplicons. During the extension step the Taq-Polymerase breaks the reporter-quencher proximity. The reporter emits a fluorescent signal which is detected by the optical unit of a real-time PCR instrument. The fluorescence signal increases with the number of formed amplicons. The Parasitic Stool Panel II assay contains an Internal Control DNA (ICD) as an internal control of sample preparation procedure and to determine possible PCR inhibition.

Parasitic Stool Panel II PCR Kit

86-PS2HU-100

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

 ALPCO Glucagon ELISA
Spotlight: ALPCO Glucagon ELISA
The ALPCO Glucagon ELISA is for the quantitative determination of glucagon in human EDTA plasma. This assay was developed for ease-of-use and demonstrates superior sensitivity while eliminating cross-reactivity issues present in other commercially-available assays. 
View Now
Accuracy in Calprotectin Testing
Accuracy in Calprotectin Testing
ALPCO’s automated turbidimetric solution for calprotectin testing offers enhanced efficiency without compromising clinical sensitivity or specificity. Clinicians can prioritize endoscopic evaluation for the patients that need it most and quickly put IBS patients on the right treatment path. 
View Now
Clinical Lab on Fecal Calprotectin Testing
Live Webinar: A Clinical Laboratory’s Perspective on Fecal Calprotectin Testing
Join our speaker from Department of Pathology , University of Utah School of Medicine, Dr. Heather Nelson, to discuss how to validate and launch a FDA-approved assay.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.